Funded Research

Distinguished Innovator Award (DIA)

The Distinguished Innovator Award (DIA) ($1 million over four years) provides outstanding scientists with substantial support to conduct novel research into the fundamental causes of systemic lupus erythematosus (SLE).

2020 Funded Grants

Characterization of conventional dendritic cells from SLE patients

Jacques Banchereau, PhD
The Jackson Laboratory for Genomic Medicine

Epigenetic regulation of pathogenic B cells in SLE

Ignacio Sanz, MD
Emory University

A novel therapeutic approach for SLE

Fabienne Mackay, PhD
QIMR Berghofer Medical Research Institute

Metabolic networks and unbiased genetic screens to identify targets for SLE

Jeffrey Rathmell, PhD
Vanderbilt University School of Medicine

Dissecting the immune landscape in lupus nephritis

Nir Hacohen, PhD
Broad Institute

Immunoregulatory mechanisms in systemic lupus

Vijay K Kuchroo DVM, PhD
Brigham and Women's Hospital

B-cell control point dysregulation in African Americans in SLE

John Mountz, MD, PhD
The University of Alabama at Birmingham

Local factors contributing to pathogenesis of proliferative lupus nephritis

Shu Man Fu, MD, PhD
University of Virginia

Origin, regulation and therapeutic targeting of extracellular DNA

Boris Reizis, PhD
New York University School of Medicine

Archive of dia grants

Distinguished Innovator Award (DIA) Lupus Mechanisms and Targets Award (LMTA) Lupus Innovation Award (LIA) LRA-BMS Accelerator Awards (BMS) Common Mechanisms in Autoimmunity Global Team Science Award

See a term you don't understand? Click to search our glossary.